Nevada · AB 259 · 2025Vetoed

Prescription drug price caps tied to Medicare rates

Would have capped certain prescription drug prices at the maximum fair prices negotiated by Medicare under the federal Inflation Reduction Act. Vetoed, with the Governor citing concerns it would raise costs and reduce access to care.

Status: Vetoed by Governor Lombardo
Status date: 2025-06-12
State: Nevada
Session year: 2025

Topics

Drug Pricing & Access

Want to weigh in on this bill?

Find your representatives and let them know how this issue affects you.

Contact your representatives

Related bills

Washington · SB 5981

340B Prescription Drug Discount Program

Enacted

Strengthens state oversight of the 340B program so discounted drug pricing intended for safety-net clinics and hospitals actually reaches patients.

Drug Pricing & Access

Washington · HB 2613

Compounded Medication Safety

Pending Verification

Sets safety standards for pharmacies that compound custom medications to reduce contamination and dosing errors.

Drug Pricing & AccessPatient Rights & Privacy

Washington · SB 5326

Emergency Insulin Supplies

Pending Verification

Allows pharmacists to dispense a short emergency supply of insulin to patients who run out and can't immediately reach their doctor.

Drug Pricing & AccessEmergency Care